Healthcare Services

Multiomics Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Multiomics Market By The End Of 2030?

The multiomics market has experienced substantial expansion recently. Its size is projected to expand from $3.85 billion in 2025 to $4.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.6%. Historically, this growth was primarily driven by the increasing adoption of genomic sequencing, the early advancements in transcriptomics tools, enhanced availability of proteomic analysis platforms, the expansion of biomarker identification research, and a general increase in biological data generation.

The multiomics market is poised for significant expansion over the coming years. By 2030, its valuation is projected to reach $8.07 billion, demonstrating a compound annual growth rate (CAGR) of 15.6%. This anticipated growth during the forecast period stems from factors such as progress in multiomics platforms, an increasing need for personalized medicine, greater incorporation of AI-driven analytics, the expanding application of metabolomics in clinical environments, and the widening use of multiomics in precision agriculture. Key developments expected in the forecast timeframe encompass the increasing embrace of single-cell multiomics, enhanced integration of diverse biological data layers, greater utilization of multiomics for early disease detection, the broadening role of multiomics in drug discovery processes, and its growing utility in agricultural genomics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Drivers Are Shaping The Future Growth Of The Multiomics Market?

The increasing requirement for personalized medicine is projected to fuel the expansion of the multiomics market going forward. Personalized medicine refers to a medical approach that customizes healthcare decisions and treatments for individual patients based on their genetic, environmental, and lifestyle factors. This personalized medicine approach is growing due to technological advancements, a heightened demand for targeted therapies, and improvements in global healthcare. Multiomics assists personalized medicine by providing a detailed understanding of an individual’s genetic, molecular, and metabolic profile, enabling healthcare providers to tailor treatments based on each patient’s specific characteristics. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the multiomics market.

Which Segment Classifications Shape The Multiomics Market?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

How Are Trends Transforming The Multiomics Market Landscape?

Leading companies in the multiomics market are engaged in developing sophisticated single-cell multiomics platforms designed to empower scientists to conduct extensive studies without compromising sample quality. These single-cell multiomics platforms integrate various omics disciplines with artificial intelligence capabilities, allowing users to effortlessly analyze and interpret intricate biological data through advanced algorithms and machine learning techniques. For instance, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system enables scientists to isolate, barcode, and analyze single cells with high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, providing the flexibility to analyze multiple samples and different cell sizes and types simultaneously, such as stem cells or cancer cells, thereby enhancing researchers’ capacity to gain greater insights in less time.

Which Companies Are Expanding Their Footprint In The Multiomics Market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Read the full multiomics market report here:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Geographic Regions Are Influencing Demand In The Multiomics Market?

North America was the largest region in the multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Multiomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Browse Through More Reports Similar to the Global Multiomics Market 2026, By The Business Research Company

Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Tumor Profiling Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer Profiling Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795